Matt Hancock says every adult will be offered vaccine by Autumn
The UK has now approved three coronavirus vaccines from Pfizer/BioNTech, Oxford University/AstraZeneca and Moderna. Vaccine rollout has started in the UK, and some two million people have now received their first dose of the vaccine. According to Health Secretary Matt Hancock, 200,000 people are receiving their Covid vaccinations every day in the UK.
Mr Hancock also said the Government is on track to hit its target of vaccinating 13 million people against coronavirus by mid-February.
The approval of the Oxford vaccine last year was significant to the UK vaccine rollout programme, as the UK has ordered 100 million doses of the vaccine.
Unlike the Pfizer vaccine, which has to be stored in -70C conditions to reach maximum efficacy, the Oxford vaccine can be kept at temperatures of 2C to 8C.
The Oxford vaccine is easier to roll out to patients in care homes, as it can be kept in similar conventional fridge settings for up to six months and administered within existing healthcare settings.
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.
How effective is the Oxford vaccine?
Clinical trials for the Oxford University/AstraZeneca vaccine involved more than 24,000 participants in the UK, Brazil and South Africa.
Phase three trials of the Oxford/AstraZeneca vaccine show the vaccine is 70.4 percent effective on average.
Data published in early December demonstrated the vaccine was 62 percent effective in preventing Covid-19 when administered in two standard doses.
When trial participants were given half a first dose of the vaccine, and later a full second dose, there was 90 percent protection against the virus.
The vaccine has passed rigorous safety checks and is shown to provoke an immune response in people of all ages, including the elderly.
MHRA Chief Executive, Dr June Raine, said of the Oxford vaccine’s approval: “We are delighted to announce the good news that the Oxford University/AstraZeneca vaccine for Covid-19 is now approved for supply following a robust and thorough assessment of all the available data.”
Dr Raine added: “No stone is left unturned when it comes to our assessments.
“This approval means more people can be protected against this virus and will help save lives.”
DON’T MISS:
‘I’m trying to give you a serious answer!’ Whitty snaps at BBC host [VIDEO]
Royal fury as cruel social media users hit out at Queen & Philip jab [ANALYSIS]
Coronavirus update: Boots to deliver first vaccination site in Halifax [INSIGHT]
How many doses do you need of the Oxford vaccine?
The MHRA has approved the use of two full doses of the Oxford vaccine.
Initially, the MHRA aimed for the second dose of the vaccine to be administered between four and 12 weeks after the first dose.
However as Covid cases remain at concerning levels in the UK, the Joint Committee on Vaccination and Immunisation (JCVI) has introduced changes to vaccine administration in the UK.
People will still receive two doses of the Oxford/AstraZeneca vaccine, however the JCVI now advises the maximum gap between the first and second doses of the vaccine is 12 weeks.
This change has been implemented to vaccinate as many people as possible with the first dose of the vaccine.
A statement from the JCVI said: “The committee advises initially prioritising delivery of the first vaccine dose as this is highly likely to have a greater public health impact in the short term and reduce the number of preventable deaths from Covid-19.”
The JCVI added: “High protection against hospitalisation was seen from 21 days after dose 1 until 2 weeks after the second dose, suggesting that a single dose of the AstraZeneca vaccine will provide high short-term protection against severe disease.
“Protective immunity from the first dose likely lasts for a duration of 12 weeks.”
Source: Read Full Article